Gil Hevroni, M.D.

So grateful to be part of such a dedicated team and discuss important strides In #MultipleMyeloma #MMawarenessmonth @SylvesterCancer

Today is great day in the journey to cure myeloma. Thank you to all the brave patients signing up to this amazing trial

Ozzy Forever!

This is for Kfir and Ariel. Share this 🟧 in support of the Bibas family. May their memory be a blessing.

Starting 2025 with warmth, laughter, and great company! 🥂🎉 Grateful for a sunny breakfast brunch at our home, celebrating new beginnings with @SylvesterCancer Hem/Onc fellowship family. Cheers to a year of growth and camaraderie! @Maryam_Alasfour @MichaelDurante1

Our researchers are redefining #myeloma care with immunotherapy & precision medicine. Learn how the Sylvester Myeloma Research Institute, led by @DrOlaLandgren is adapting to a field transformed by new #immunotherapy drugs and therapies: loom.ly/SN6PCXM 🔬 #ASH24 #MMSM

Almost every review I've ever read about myeloma #MMsm starts with something (true) like, "Recent advances in myeloma have led to significant improvements in..." Quite a jolt to see how different the prognosis was for myeloma 60 years ago... and how these papers used to begin!

Check out this review on myeloma precursor states: From MGUS to multiple myeloma: Unraveling the unknown of precursor sta... sciencedirect.com/science/articl… Thank you @DrOlaLandgren @Drjhoffmanmiami, @davidcoffey and the myeloma team for the mentorship and support 🙌 @SylvesterCancer

Inspirational!

Celebrating happy moments and amazing NP Suzan in #myeloma #amyloid Wednesday! @SylvesterCancer

@liviiilevine So proud of you!!

Olivia Levine, MD, PhD 🎓🩺🧠💊🔬

Eden had a sensational performance in Sweden today #Eurovision2024. In awe of her courage and talent.

Today, US FDA held an ODAC meeting to debate MRD as an endpoint to support accelerated approval in #myeloma clinical trials. Two groups (@SylvesterCancer and i2TEAMM) presented retrospective data from clinical trials that measured MRD. Final vote was 12-0 in favor.

IMF celebrates ODAC's historic decision on MRD testing as an early endpoint for accelerated myeloma drug approval. 10 yrs of IMF research led by Dr. Durie & i2TEAMM; & U of Miami Sylvester Comprehensive Cancer Center contributed to this decision. @BrunoPaiva_UNAV @NikhilMunshiMD

CABOMETYX shows significant reduction in risk of progression or death in patients with locally advanced/metastatic DTC that has progressed following VEGFR-targeted therapy and who are RAI-R or ineligible.¹ Visit bit.ly/48qDgjW for full Prescribing Info.

A great #myeloma #amyloid Wednesday clinic celebrating @Drjhoffmanmiami birthday 🎉 @SylvesterCancer #dreamteam 🙌 🩸 #hemeteam

My best friend is coming to UMiami for urogyn! ♥️

Theme of hematology consult week: Acute DVT on AC. Assess for treatment failure… how often is it really a TRUE failure?

In today's noisy world, so many opinions are expressed all around us. Having views on things often shows that you care, and a healthy debate can widen our perspective. But it's important for opinions and arguments to be based on facts that can be scientifically validated, as far as possible. People are entitled to have their own views, but they are not entitled to have their own facts. #quotes #science #facts #knowledge

@AsaadTrabolsi @AaronGoodman33 @DrPlatelet Totally agreed!

@AaronGoodman33 @GilHevroni @DrPlatelet we should consider these!